Company intelligence / Profile preview

Katakem

Caraffa di Catanzaro, Calabria, Italykatakem.com ↗

Ownership: Private
Development stage: Other

Overview

Katakem has developed the patented OnePot autonomous batch reactor, enabling fully automated, highly reproducible chemical process development and scale-up. Their technology allows instant digitalization and sharing of processes globally. Early collaborations include academic research published in ACS Sustainable Chemistry & Engineering. The company projects strong revenue growth as adoption increases among pharma/biotech manufacturers.

Modalities: Device (automation platform for chemical synthesis)Small molecule (enables small molecule synthesis, but not a drug developer itself)
Industry: Drug Discovery Services

Partnerships

Magna Graecia University of Catanzaro (UMG) – academic collaboration

Beyond the preview

Go deeper on Katakem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Katakem.

Explore the full profile